The non-hospital-based point-of-care diagnostic products market is likely rise to a USD 12.9 billion valuation in 2022. The demand for non-hospital-based point-of-care diagnostic products is estimated to reach USD 33.6 Billion by 2032, with a CAGR of 9.1% during the forecast period.
| Report Attribute | Details |
|---|---|
| Non-Hospital-Based Point-Of-Care Diagnostic Products Market Value (2022) | USD 12.9 Billion |
| Non-Hospital-Based Point-Of-Care Diagnostic Products Market Anticipated Forecast Value (2032) | USD 33.6 Billion |
| Non-Hospital-Based Point-Of-Care Diagnostic Products Market Projected Growth Rate (2022 to 2032) | 9.1% |
The demand for non-hospital-based point-of-care diagnostic products is rising due to the availability of various self-test kits and devices. In addition to this, these are widely used in home care settings, and clinics are anticipated to enlarge the non-hospital-based point-of-care diagnostic products market share in the coming forecast period from 2022 to 2032.
The adoption of on-hospital-based point-of-care diagnostic products is in-vitro diagnostic medical devices that have a medical purpose. The sales of non-hospital-based point-of-care diagnostic products are likely to increase as they are used to diagnose a variety of conditions or to monitor a particular treatment.
The non-hospital-based point-of-care diagnostic products market growth is rapidly expanding owing to cost-effectiveness and comfort level during the forecast period. The adoption of non-hospital-based point-of-care diagnostic products is commonly required for pregnancy tests and test kits for measuring blood sugar.
The non-hospital-based point-of-care diagnostic products provided to patients are anticipated to empower clinicians to address healthcare challenges and make decisions instantly.
The extensive use of non-hospital-based point-of-care diagnostic products boosts the non-hospital-based point-of-care diagnostic products market size over the forecast period from 2022 to 2032.
Non-hospital-based point-of-care diagnostic products market demand analysis gives the accuracy, reliability, and efficiency for the end-user and is expected to fuel the non-hospital-based point-of-care diagnostic products market growth. Growing demand for Non-hospital-based point-of-care diagnostic products in emerging countries also creates tremendous opportunity during the forecast period.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The increasing geriatric population, rising incidence of diabetes, and unmet need for home care are growing the non-hospital-based point-of-care diagnostic products market trends in recent years.
The growing prevalence of target diseases coupled with an increase in the geriatric population base, which is more prone to disease development and needs home care and monitoring, is anticipated to rise in the non-hospital-based point-of-care diagnostic products market future trends over the forecast period.
Technology advancement, cost-effective products, and high accuracy are the factors that are anticipated to grow the non-hospital-based point-of-care diagnostic products market key trends & forecast in the coming year. Moreover, the availability of advanced rapid diagnostic tests and increasing awareness have also boosted the growth of non-hospital-based point-of-care diagnostic products market analysis over the forecast period.
However, improper care of equipment, lack of quality control, and poor training can hamper the global non-hospital-based point-of-care diagnostic products market growth over the forecast period from 2022 to 2032.
By region, the global non-hospital-based point-of-care diagnostic products market share is anticipated to dominate the North American region during the forecast period from 2022 to 2032.
North America acquires 33.2% of the share in the non-hospital-based point-of-care diagnostic products market share all around the region. Due to the high incidence of metabolic disease moreover, favourable government regulations and initiatives for the development of healthcare infrastructure are expected to result in higher demand for Non-hospital-based point-of-care diagnostic products over the forecast period.
Principal Consultant
The Europe region is expected to be the most attractive region that stood in second place in the non-hospital-based point-of-care diagnostic products market size acquiring 29.8% of the share during the forecast period from 2022 to 2032.
Due to owing to the presence of high unmet medical needs and constantly improving healthcare infrastructure, growing medical awareness, and a rise in per capita income are likely to grow the non-hospital-based point-of-care diagnostic products market key trends & opportunities in the region.
Recently, the non-hospital-based point-of-care diagnostic products market trends are growing & focusing on consumers' needs, cost-saving supply chains, and automation which are anticipated to acquire a significant non-hospital-based point-of-care diagnostic products market growth in recent years.
The non-hospital-based point-of-care diagnostic product statistics are developing in microfluidic, assay formats, biosensors, bioanalytical platforms, and other complementary techniques during the forecast period from 2022 to 2032.
A biosensor is one of the effective components of non-hospital-based point-of-care diagnostic products, which directly affects the bioanalytical performance. Some of the biosensors are surface plasmon and white light reflectance spectroscopy, and others are likely to develop to improve the non-hospital-based point-of-care diagnostic products market share.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The key players in the Non-hospital-based point-of-care diagnostic products market are Abbott Laboratories Inc., Siemens Healthcare GmbH, Bio Rad Laboratories Inc., Thermo Fisher Scientific Inc., and Roche Diagnostics (H. Hoffman-La Roche Ltd.), STD Rapid Test Kits, etc.
Most of the companies sell their products through medical equipment distributors that operate in different regions and the distribution network and market presence are likely to grow the sales of non-hospital-based point-of-care diagnostic products in recent years.
Recent Development in the Non-Hospital-Based Point-Of-Care diagnostic Products Market are:
| Report Attribute | Details |
|---|---|
| Growth Rate | CAGR of 9.1% from 2022 to 2032 |
| Base Year for Estimation | 2021 |
| Historical Data | 2016 to 2021 |
| Forecast Period | 2022 to 2032 |
| Quantitative Units | Revenue in USD Million and CAGR from 2022 to 2032 |
| Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis |
| Segments Covered | Product Type, End User, Region |
| Regions Covered | North America; Latin America; Europe; East Asia; South Asia; Oceania; Middle East and Africa |
| Key Countries Profiled | USA, Canada, Brazil, Argentina, Germany, UK, France, Spain, Italy, Nordics, BENELUX, Australia & New Zealand, China, India, ASEAN, GCC, South Africa |
| Key Companies Profiled | Abbott Laboratories Inc.; Siemens Healthcare GmbH; Bio Rad Laboratories Inc.; Thermo Fisher Scientific Inc.,; Roche Diagnostics (H. Hoffman-La Roche ;Ltd.); STD Rapid Test Kits |
| Customization | Available Upon Request |
The non-hospital-based point-of-care diagnostic products market is likely to advance at a CAGR of 9.1% through 2032.
The North American region holds a non-hospital-based point-of-care diagnostic products market share of 33.2% by 2032.
The non-hospital-based point-of-care diagnostic products market is anticipated to expect USD 12.9 Billion in 2022.
The non-hospital-based point-of-care diagnostic products market is expected to account for USD 33.6 Billion by 2032.
1. Executive Summary 2. Market Overview 3. Market Background 4. Global Non to Hospital to Based Point to Of to Care Diagnostic Products Market Analysis 2017 to 2021 and Forecast, 2022 to 2032 5. Global Non to Hospital to Based Point to Of to Care Diagnostic Products Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Product Type 5.1. Paper to based Test Kit 5.1.1. Pregnancy Test Kit 5.1.2. Infection Test Kit 5.1.3. Glucose Test Kit 5.1.4. Others 5.2. Analyzer 5.2.1. Glucose Monitor 5.2.2. Pulse Oximetry 5.2.3. Others 6. Global Non to Hospital to Based Point to Of to Care Diagnostic Products Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By End User 6.1. Diagnostic Clinics 6.2. Homecare Settings 6.3. Clinics 6.4. Others 7. Global Non to Hospital to Based Point to Of to Care Diagnostic Products Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Region 7.1. North America 7.2. Latin America 7.3. Europe 7.4. Asia Pacific 7.5. MEA 8. North America Non to Hospital to Based Point to Of to Care Diagnostic Products Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country 9. Latin America Non to Hospital to Based Point to Of to Care Diagnostic Products Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country 10. Europe Non to Hospital to Based Point to Of to Care Diagnostic Products Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country 11. Asia Pacific Non to Hospital to Based Point to Of to Care Diagnostic Products Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country 12. MEA Non to Hospital to Based Point to Of to Care Diagnostic Products Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country 13. Key Countries Non to Hospital to Based Point to Of to Care Diagnostic Products Market Analysis 14. Market Structure Analysis 15. Competition Analysis 15.1. Abbott Laboratories Inc. 15.2. Siemens Healthcare 15.3. Bio Rad Laboratories Inc. 15.4. Thermo Fisher Scientific 15.5. Roche Diagnostics 15.6. STD Rapid Test Kits 16. Assumptions & Acronyms Used 17. Research Methodology
Explore Healthcare Insights
View Reports
Non-Hospital-Based Point-Of-Care Diagnostic Products Market
